Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
Tortugas Neuroscience is a neurology-focused biotech company developing novel medicines.
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.
Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Tr1x is a biotechnology company developing novel cellular immunotherapies for patients with autoimmune and inflammatory diseases.
Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.
Kimia is a drug discovery company applying high throughput precision chemistry in combination.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Velia is a biotech company that discovers and develops the therapeutic potential of human proteins.
NILO Therapeutics is a biotechnology and therapeutics company.
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.
The Column Group has invested in 42 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
The Column Group's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 12 different industry categories.
Among tracked funding rounds, Revolution Medicines received $1.5B in a Post-IPO Equity round. The Column Group's total known invested capital is $3.9B.
The Column Group's average investment size is $95.2M across its portfolio of 42 companies.
Recent The Column Group portfolio additions include Circle Pharma, Nura Bio, A2 Biotherapeutics, ORIC Pharmaceuticals, Tortugas Neuroscience. These companies were founded in 2020 or later.